---

20%~25%

5% 4.14%

10
5 69

1.
2
2.
3.
4.
5.

( 1.5 )( )

aspirin

6 8

1.Kai-Sheng Hsieh, Ken-Pen Weng,

Chu -Chuan Lin, Ta-Cheng Huang,

Cheng-Liang Lee, Shih-Ming Huang.

Treatment of acute Kawasaki disease :

Aspirin s role in the febrile stage

revisited. Pediatrics 004;114:e689e692.
2.Shih-Ming Huang, Ken-Pen Weng,
Jeng-Sheng Chang, MD, Wei-Yang

Lee, Shih-Hui Huang, Kai-Sheng

Hsieh. Effects of Statin Therapy in
Children Complicated with Coronary
Arterial Abnormality Late After
Kawasaki Disease: A Pilot Study.
Circ J 2008; 72:1583-1587.
3.Ken-Pen Weng, Kai-Sheng Hsieh,
Tsyr -Yuh Ho, Shih-Hui Huang,
Chung -Ren Lai,Yi-Ten Chiu, Shih
-Chen Huang, Chu-Chuan Lin, YuTung Hwang, Luo-Ping Ger. IL-1B
Polymorphism in Association With
Initial IVIG Treatment Failure in
Taiwanese Children With Kawasaki
Disease. Circ J 2010;74:544-551.
4.Ken-Pen Weng, Kai-Sheng Hsieh, Yu
-Tung Hwang, et al. IL-10 polymor
-phisms are associated with coronary
artery lesions in acute stage of
Kawasaki disease. Circ J 2010;74:
983 -989.
5.Ken-Pen Weng, Tsyr-Yuh Ho, YaHui Chiao, Jiin-Tsuey Cheng, KaiSheng Hsieh, Shih-Hui Huang, Shan-F
Ou, Kai-His Liu, Ching-Ju Hsu, Pei-

Jung Lu, Michael Hsiao, Luo-Ping Ger.

Cytokine Genetic Polymorphisms and
Susceptibility to Kawasaki Disease in
Taiwanese Children. Circ J 2010, 74
Mar: 2726-2733.
6.Kai-Sheng Hsieh, Tsung-Jen Lai, YuTung Hwang, Ming-Wei Lin, Ken-Pen
Weng, etc. IL-10 promoter genetic
polymorphisms and risk of Kawasaki
disease in Taiwan. Disease Markers
2011 Jan;30:51-9.
7.Ken-Pen Weng; Shan-F Ou; ChuChuan Lin; Kai-Sheng Hsieh. Recent
Advances in The Treatment of Kawasaki
disease. J Chin Med Assoc 2011, 74:
481-484.
8.Ken-Pen Weng; Kai-Sheng Hsieh;
Shih-Hui Huang; Shan-F Ou; Chun
-Yen Ma; Tsyr-Yuh Ho; Chung-Ren
Lai; Luo-Ping Ger. Clinical Relevance
of the Risk Factors for Coronary
Artery Lesions in Kawasaki Disease.
Kaohsiung journal of medical sciences
2012, 28:23-29.

102.7.24
II